Difference between revisions of "Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3) (Q10737)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: named entity (P78): Cardiomyopathies (disease - MeSH descriptor) (Q10853), #quickstatements; #temporary_batch_1592945260289)
(‎Created claim: named entity (P78): COVID-19 (disease - MeSH supplementary concept) (Q7804), #quickstatements; #temporary_batch_1592945260289)
Property / named entity
 +
Property / named entity: COVID-19 (disease - MeSH supplementary concept) / rank
 +
Normal rank

Revision as of 20:47, 23 June 2020

Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3
Language Label Description Also known as
English
Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3)
Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3

    Statements